Progress through partnership for diseases of poverty
ISNTD d3 2022
Drug discovery, development & diagnostics
for neglected tropical diseases
Online conference
29-30th June 2022
#ISNTDd3
#beatNTDs
Introduction
ISNTD d³ 2022 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities.
This year, against the backdrop of the recently launched WHO NTD Roadmap and the shock of the COVID19 pandemic, ISNTD d³ will focus on the shifts, gaps and future needs of drug discovery, treatments and diagnostics in context of global health as well as broader challenges.
Presentations & panel discussions will run on both days, and partnership meetings can be arranged throughout the day.
Please contact krafiq@isntd.org for further details including speaking & attending and to become a conference sponsor.
Programme
DRUG DISCOVERY & DEVELOPMENT
ISNTD d3 2022: DAY 1
29 JUNE 2022
Session 1
Pipeline updates
Session 2
The future of vaccines for NTDs, from manufacturing to access
Session 3
Challenges in financing new development in NTDs
Béatrice Greco - Head of R&D and Access strategy of the Merck Global Health Institute, Merck
Isaac T. Chikwanha, Senior Director, Investment Strategy, Access & Delivery, GHIT - Global Health Innovative Technology Fund
Kishor Wasan Adjunct Professor & Distinguished University Scholar
Co-Director & Co-Founder, Neglected Global Diseases Initiative-University of British Colombia
Session 4
Disease focus: sleeping sickness, de-risking discovery through partnerships and driving sustainability through access
Philippe Neau Head of Neglected Tropical Diseases Program at Global Health Sanofi
Florent Mbo Access Leader and Regional HATplatform Coordinator
Drugs for Neglected Diseases initiative (DNDi), RDC
François Bompart DNDi ,Access Committee Chair, DNDi
DIAGNOSTICS FOR NEGLECTED TROPICAL DISEASES
ISNTD d3 2022: DAY 2
30 JUNE 2022
Session 1
NTD diagnostics & the future of disease elimination
Dr. Sarah Nogaro FIND
Session 2
Novel point-of-care diagnostics
Digital optical diagnostics for schistosomiasis and the Schistoscope
Dr. Temitope Agbana (Post-Doc, Delft University of Technology TU Delft and INSPiRED project)
Cygnus smartphone multiplex microcapillary diagnostics for rapid serotype-specific NS1 detection of dengue
Dr Alexander Edwards (Reading School of Pharmacy, University of Reading UK)
A handheld quantitative G6PD diagnostic tool to improve point-of-care malaria diagnosis
Dr Benedikt Ley (Senior Research Fellow, Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Australia)
Session 3
Molecular-based diagnostics for NTDs
Multiplex real-time qPCR assay for leprosy diagnosis
Dr Alexandre Dias Tavares Costa (Instituto de Biologia Molecular do Paraná, FIOCRUZ, Curitiba, Brazil, Laboratório de Ciências e Tecnologias Aplicadas à Saúde (LaCTAS), Instituto Carlos Chagas, Fundação Oswaldo Cruz/FIOCRUZ)
“Mail order” RNA-sequencing of single tapeworm egg isolates from stool samples for the diagnosis of Taenia solium infections
Henrik Sadlowski (Charité-Universitätsmedizin Berlin; NeuroCure (NCRC)
Session 4
Novel protein candidates for NTD diagnostics
Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers
Dr Javier Sotillo (Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Australia and Instituto de Salud Carlos III, Spain)
The International Society for Neglected Tropical Diseases
